Higher proportion of inactive Gsk3β in platelets of elderly patients with bipolar disorder: An effect of treatment?

Revista Brasileira de Psiquiatria

Volumn 35, Issue 3, 2013, Pages 274-278

  Ladeira, Rodolfo Braga ^a   Joaquim, Helena Passarelli Giroud ^a   Talib, Leda Leme ^a   Nunes, Paula Villela ^a   Forlenza, Orestes Vicente ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Aged; Bipolar disorder; Blood platelets; Glycogen synthase kinase 3; Lithium

Indexed keywords

CLONAZEPAM; GLYCOGEN SYNTHASE KINASE 3BETA; LITHIUM CARBONATE; OLANZAPINE; SERINE; SERTRALINE; VALPROIC ACID;

AGED; ARTICLE; BIPOLAR DISORDER; CLINICAL ARTICLE; COGNITION; COMORBIDITY; CONTROLLED STUDY; DEPRESSION; DRUG BLOOD LEVEL; ENZYME INACTIVATION; FEMALE; HUMAN; HUMAN CELL; HYPERLIPIDEMIA; HYPERTENSION; HYPOTHYROIDISM; ION SELECTIVE ELECTRODE; MALE; MANIA; PROTEIN PHOSPHORYLATION; THROMBOCYTE;

AGED; AGED, 80 AND OVER; BIPOLAR DISORDER; BLOOD PLATELETS; CASE-CONTROL STUDIES; FEMALE; GLYCOGEN SYNTHASE KINASE 3; HUMANS; MALE; MIDDLE AGED; PHOSPHORYLATION; PSYCHOTROPIC DRUGS;

EID: 84885111742     PISSN: 15164446     EISSN: None     Source Type: Journal    
DOI: 10.1590/1516-4446-2012-0921     Document Type: Article

References (17)

1. Grimes CA, Jope RS. The multifaceted roles of glycogen synthase kinase 3beta in cellular signaling. Prog Neurobiol. 2001;65:391-426.
2. Woodgett JR. Molecular cloning and expression of glycogen synthase kinase-3/factor A. EMBO J. 1990;9:2431-8.
3. Jope RS, Roh MS. Glycogen synthase kinase-3 (GSK3) in psychiatric diseases and therapeutic interventions. Curr Drug Targets. 2006;7:1421-34.
4. Jope RS. Glycogen synthase kinase-3 in the etiology and treatment of mood disorders. Front Mol Neurosci. 2011;4:16.
5. Luykx JJ, Boks MP, Terwindt AP, Bakker S, Kahn RS, Ophoff RA. The involvement of GSK3beta in bipolar disorder: integrating evidence from multiple types of genetic studies. Eur Neuropsychopharmacol. 2010;20:357-68.
6. Pandey GN, Ren X, Rizavi HS, Dwivedi Y. Glycogen synthase kinase-3beta in the platelets of patients with mood disorders: effect of treatment. J Psychiatr Res. 2010;44:143-8.
7. Li X, Liu M, Cai Z, Wang G, Li X. Regulation of glycogen synthase kinase-3 during bipolar mania treatment. Bipolar Disord. 2010;12:741-52.
8. Polter A, Beurel E, Yang S, Garner R, Song L, Miller CA, et al. Deficiency in the inhibitory serine-phosphorylation of glycogen synthase kinase-3 increases sensitivity to mood disturbances. Neuropsychopharmacology. 2010;35:1761-74.
9. Li X, Friedman AB, Zhu W, Wang L, Boswell S, May RS, et al. Lithium regulates glycogen synthase kinase-3beta in human peripheral blood mononuclear cells: implication in the treatment of bipolar disorder. Biol Psychiatry. 2007;61:216-22.
10. American Psychiatric Association. Diagnostic and statistical manual of mental disorders-DSM-IV-TRH. 4th ed. Arlington: American Psychiatric Publishing; 2000.
11. Joaquim HP, Talib LL, Forlenza OV, Diniz BS, Gattaz WF. Long-term sertraline treatment increases expression and decreases phosphorylation of glycogen synthase kinase-3B in platelets of patients with late-life major depression. J Psychiatr Res. 2012;46:1053-8.
12. First MB, Spitzer RL, Gibbon M, Willian JBW. Structured Clinical Interview for DSM-IV-TR Axis I Disorders, research version, nonpatient edition. (SCID-I/NP). New York: Biometrics Research, New York State Psychiatric Institute; 2002.
13. Young RC, Biggs JT, Ziegler VE, Meyer DA. A rating scale for mania: reliability, validity and sensitivity. Br J Psychiatry. 1978;133:429-35.
14. Hamilton M. A rating scale for depression. J Neurol Neurosurg Psychiatry. 1960;23:56-62.
15. Roth M, Tym E, Mountjoy CQ, Huppert FA, Hendrie H, Verma S, et al. CAMDEX. A standardised instrument for the diagnosis of mental disorder in the elderly with special reference to the early detection of dementia. Br J Psychiatry. 1986;149:698-709.
16. Jope RS. Lithium and GSK-3: one inhibitor, two inhibitory actions, multiple outcomes. Trends Pharmacol Sci. 2003;24:441-3.
17. Diniz BS, Talib LL, Joaquim HP, de Paula VR, Gattaz WF, Forlenza OV. Platelet GSK3B activity in patients with late-life depression: marker of depressive episode severity and cognitive impairment? World J Biol Psychiatry. 2011;12:216-22.